After participating in a special event at the White House this week, Indiana University researcher Cris Henderson is confident that IU’s leadership in helping to prevent opioid overdoses is moving Indiana and the nation in the right direction. Henderson is a research associate for Prevention Insights and a doctoral student at the IU School of… Read more »
Tag: Uncategorized
IU faculty startup MBX Biosciences announces $163.2 million U.S. IPO
MBX Biosciences, an Indiana University faculty-created startup that develops peptide therapies for the treatment of endocrine and metabolic diseases, raised $163.2 million in its U.S. initial public offering. The company’s peptides are based on chemistry developed by a research team led by Richard DiMarchi, scientific cofounder of MBX Biosciences and Distinguished Professor of Chemistry in… Read more »
IU researcher develops anticounterfeit tags and environmental sensors using nanoparticles
From apparel to pharmaceuticals, the global impact of counterfeit goods can reach up to $1.7 trillion annually across numerous markets. To tackle this important issue, Indiana University research chemist Sara Skrabalak is using nanoparticles to develop anticounterfeit tags and environmental sensors that mark critical components to confirm if an item has been tampered with. She… Read more »
IU researcher engineers data-processing architectures in fibers
To meet the demands of the Internet of Tomorrow, Indiana University researcher and entrepreneur Alexander Gumennik is advancing smart fibers that could lead to improvements in the management of biomedical and biohazardous materials, the monitoring of our environment and the human body, optical treatments and more. Gumennik is interested in collaborating with industry partners to… Read more »
Patents awarded to six IU innovations
Six Indiana University-led technologies and methods have recently received patents from the U.S. Patent and Trademark Office. These innovations include an antiviral drug treatment for HPV, as well as methods for activating T cells in vitro, processing speech, enhancing the study of the gut microbial ecosystem, analyzing lipoproteins through the use of mass spectrometry and… Read more »
IU researcher pioneers new class of antibiotics to treat infectious diseases
An Indiana University researcher is pioneering an innovative approach to develop new antibiotics that could help address the growing problem of bacterial antimicrobial resistance, which is when bacteria and viruses no longer respond to antibiotic medicines. Recent estimates indicate that each year there are 5 million infections globally associated with bacterial antimicrobial resistance, with 1.3… Read more »
IU researcher uses revolutionary method to develop anticancer therapeutics
When developing anticancer therapeutics, most researchers aim to kill cancerous cells. However, Hiroki Yokota’s approach is to control their growth by knowing how to grow them. Yokota, a professor of biomedical engineering at the School of Engineering and Technology at IUPUI, an adjunct professor of anatomy, cell biology and physiology at the IU School of… Read more »
IU lecturer making waves in the VR/AR realm
Zeb Wood, a lecturer of media arts and science at the Indiana University Luddy School of Informatics, Computing and Engineering at Indianapolis, has been one of the leading frontrunners of IU innovation in virtual and augmented reality. Drawing upon a background in 3D animation, Wood has had a string of successes in advancing these prominent… Read more »
IU bioengineers are building the intersection of brain organoids and AI
Feng Guo, an associate professor of intelligent systems engineering at the Indiana University Luddy School of Informatics, Computing and Engineering, is addressing the technical limitations of artificial intelligence computing hardware by developing a new hybrid computing system—which has been dubbed “Brainoware”—that combines electronic hardware with human brain organoids. Advanced AI techniques, such as machine learning… Read more »
IU researcher’s drug to slow diabetic retinopathy successfully completes Phase 2 trial
Mark R. Kelley, the Betty and Earl Herr professor of pediatric oncology research at the Indiana University School of Medicine and associate director of basic science at the IU Melvin and Bren Simon Comprehensive Cancer Center, is celebrating the positive Phase 2 trial results of a first-of-its-kind drug he developed to slow the progression of… Read more »